FDA
approval
· 2020-01-23
FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Camber Pharmaceuticals’ generic tenofovir disoproxil fumarate.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE)